Logan Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12K Hold
16
﹤0.01% 419
2025
Q1
$1.18K Hold
16
﹤0.01% 503
2024
Q4
$1.05K Buy
+16
New +$1.05K ﹤0.01% 484
2023
Q3
Sell
-15
Closed -$1.07K 488
2023
Q2
$1.07K Sell
15
-37,733
-100% -$2.7M ﹤0.01% 467
2023
Q1
$2.62M Buy
37,748
+233
+0.6% +$16.2K 0.13% 156
2022
Q4
$2.54M Buy
37,515
+1,438
+4% +$97.5K 0.13% 154
2022
Q3
$1.98M Sell
36,077
-4,244
-11% -$233K 0.12% 156
2022
Q2
$2.66M Buy
40,321
+5,155
+15% +$341K 0.15% 139
2022
Q1
$2.33M Buy
35,166
+5,071
+17% +$336K 0.11% 157
2021
Q4
$1.75M Buy
30,095
+2,008
+7% +$117K 0.08% 182
2021
Q3
$1.69M Buy
28,087
+324
+1% +$19.5K 0.08% 182
2021
Q2
$1.66M Buy
27,763
+3,145
+13% +$188K 0.08% 179
2021
Q1
$1.23M Buy
24,618
+446
+2% +$22.2K 0.06% 198
2020
Q4
$1.21M Sell
24,172
-440
-2% -$22K 0.06% 203
2020
Q3
$1.35M Buy
24,612
+1,470
+6% +$80.6K 0.07% 221
2020
Q2
$1.22M Buy
23,142
+850
+4% +$45K 0.07% 172
2020
Q1
$996K Sell
22,292
-3,000
-12% -$134K 0.07% 203
2019
Q4
$1.26M Buy
25,292
+336
+1% +$16.8K 0.07% 185
2019
Q3
$1.11M Sell
24,956
-1,156
-4% -$51.5K 0.07% 193
2019
Q2
$1.08M Buy
26,112
+1,159
+5% +$47.8K 0.06% 185
2019
Q1
$1.01M Sell
24,953
-2,144
-8% -$86.7K 0.06% 190
2018
Q4
$1.03M Buy
27,097
+2,096
+8% +$79.6K 0.08% 160
2018
Q3
$990K Sell
25,001
-672
-3% -$26.6K 0.06% 184
2018
Q2
$901K Buy
25,673
+927
+4% +$32.5K 0.06% 191
2018
Q1
$866K Sell
24,746
-1,294
-5% -$45.3K 0.06% 189
2017
Q4
$904K Buy
26,040
+1,710
+7% +$59.4K 0.06% 180
2017
Q3
$824K Buy
24,330
+2,003
+9% +$67.8K 0.06% 191
2017
Q2
$761K Buy
22,327
+377
+2% +$12.9K 0.06% 188
2017
Q1
$684K Sell
21,950
-2,580
-11% -$80.4K 0.05% 197
2016
Q4
$670K Sell
24,530
-86
-0.3% -$2.35K 0.05% 204
2016
Q3
$809K Buy
24,616
+547
+2% +$18K 0.07% 181
2016
Q2
$726K Buy
24,069
+4,371
+22% +$132K 0.06% 183
2016
Q1
$554K Buy
19,698
+109
+0.6% +$3.07K 0.04% 232
2015
Q4
$665K Buy
19,589
+194
+1% +$6.59K 0.05% 204
2015
Q3
$617K Sell
19,395
-495
-2% -$15.7K 0.05% 211
2015
Q2
$634K Buy
+19,890
New +$634K 0.05% 223